Journal profile · Pediatrics
Journal of Pediatric Hematology/Oncology
ISSN 1077-4114 · eISSN 1536-3678 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1995
Journal of Pediatric Hematology/Oncology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.88; JCR Q3 (journal website); hybrid open access; median 152 days to acceptance (113 articles, last 24 months); community-reported acceptance: about 25%; 172 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Pediatric Hematology/Oncology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life and Hemoglobinopathies and Related Disorders, together about 28.4% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
Journal of Pediatric Hematology/Oncology (JPHO) reports on major advances in the diagnosis and treatment of cancer and blood diseases in children. The journal publishes original research, commentaries, historical insights, and clinical and laboratory observations.
Source: LetPub
Research area (LetPub): Pediatrics
Editor-in-chief Bruce M. CamittaPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Acute Lymphoblastic Leukemia researchMedicine11.2%
- Childhood Cancer Survivors' Quality of LifeMedicine8.7%
- Hemoglobinopathies and Related DisordersMedicine8.5%
- Acute Myeloid Leukemia ResearchMedicine6.1%
- Neuroblastoma Research and TreatmentsMedicine6%
- Sarcoma Diagnosis and TreatmentMedicine4.9%
- Hematopoietic Stem Cell TransplantationMedicine4.6%
- Blood groups and transfusionMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Pediatrics | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Pediatrics | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Oncology | Zone 4 |
| Minor | Pediatrics | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q4 · HEMATOLOGY · rank 90/103
- JCR Q4 · ONCOLOGY · rank 304/333
- JCR Q3 · PEDIATRICS · rank 140/190
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.88LetPub ·
- Impact factor (publisher)
- 0.9Publisher website ·
- CiteScore 2026-06
- 1.8LetPub ·
- SJR 2026-06
- 0.35LetPub ·
- SNIP 2026-06
- 0.45LetPub ·
- h-index
- 72LetPub ·
- h-index
- 100OpenAlex ·
- i10-index
- 3,249OpenAlex ·
- 2-year mean citedness
- 0.96OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 6%LetPub ·
Volume
- Articles per year
- 153LetPub ·
Articles by year OpenAlex count · 8,111 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 126 | 11 | 10 |
| 2025 | 172 | 11 | 119 |
| 2024 | 180 | 22 | 330 |
| 2023 | 199 | 24 | 522 |
| 2022 | 219 | 31 | 795 |
| 2021 | 352 | 47 | 1,574 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
152 daysMedian, submission to acceptance · P25–P75 104 days – 249 days
- Acceptance to online
- median 33 days (113 articles)
- Submission to online
- median 196 days
- Sample
- 113 articles with submission and acceptance dates (325 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 2.5 monthsLetPub ·
- Average acceptance (community reports)
- 25%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1995
- ISSN
- 1077-4114
- Electronic ISSN
- 1536-3678
- Latest issue on the website
- Volume 48, Issue 6 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about Journal of Pediatric Hematology/Oncology
What CAS zone is Journal of Pediatric Hematology/Oncology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pediatric Hematology/Oncology is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology / Oncology / Pediatrics. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Pediatric Hematology/Oncology?
The latest impact factor listed by LetPub is 0.88; CiteScore 1.8, h-index 100.
How long does peer review take at Journal of Pediatric Hematology/Oncology?
Based on the dates recorded on 113 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 152 days (interquartile range 104–249 days); authors report an average review time of about 2.5 months; the community-reported acceptance is “about 25%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Journal of Pediatric Hematology/Oncology in?
The journal's website gives JCR Q3; by category, HEMATOLOGY Q4 (90/103), ONCOLOGY Q4 (304/333), PEDIATRICS Q3 (140/190). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Journal of Pediatric Hematology/Oncology?
According to LetPub and DOAJ records, Journal of Pediatric Hematology/Oncology is indexed in SCIE and Scopus.
Is Journal of Pediatric Hematology/Oncology open access, and what is the APC?
Journal of Pediatric Hematology/Oncology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .